Manuel Rodríguez‐Perálvarez

Author

Hospital Universitario Reina Sofía ORCID

Also Known As

José Luis Montero-Álvarez, M Rodríguez-Perálvarez, M. Rodriguez-Peralvarez, M. Rodriguez-Perálvarez, M. Rodriguez‐Peralvarez, M. Rodríguez-Perálvarez, M.L. Rodriguez Perálvarez, Manolo Rodriguez-Peralvarez, Manuel L. Rodriguez‐Peralvarez, Manuel L. Rodríguez Perálvarez

198

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Reina Sofía Instituto Maimónides de Investigación Biomédica de Córdoba Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas University of Córdoba The Royal Free Hospital

About

Manuel Rodríguez‐Perálvarez is an author at Hospital Universitario Reina Sofía specializing in medicine, hepatology, and liver transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.2K
2	Natural Sciences	2	2	46
3	Biochemistry	2	2	46
4	Health Sciences	1	1	29
5	Public Health	1	1	73

Manuel Rodríguez‐Perálvarez

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients Jordi Colmenero, Manuel Rodríguez‐Perálvarez, Magdalena Salcedo, Journal of Hepatology	2020	317
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients James Neuberger, Wolf O. Bechstein, Dirk Kuypers, Transplantation Practical RecommendationsLiver Transplant RecipientsLiver Transplant SpecialistsSolid Organ TransplantationSurgery	2017	297
Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma Manuel Rodríguez‐Perálvarez, Emmanuel Tsochatzis, María Carmen Naveas, Journal of Hepatology HepatologyMedicinePharmacologyPathologyHepatotoxicity	2013	248
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy Sowsan Atabani, Colette Smith, Claire Atkinson, American Journal of Transplantation	2012	209
Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome Manuel Rodríguez‐Perálvarez, Giacomo Germani, Vasilios Papastergiou, Journal of Hepatology Transplant RejectionTransplantationHepatologyLiver PhysiologyImmunology	2012	121
Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease Mercedes del Río-Moreno, Emilia Alors‐Pérez, Sandra González‐Rubio, The Journal of Clinical Endocrinology & Metabolism	2019	100
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation Manuel Rodríguez‐Perálvarez, Jordi Colmenero, Antonio González, American Journal of Transplantation HepatologyMedicineCumulative ExposureTransplantation MedicinePathology	2022	94
Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization Rubén Ciria, Pedro López‐Cillero, Arsenio Gallardo, European Journal of Surgical Oncology Surgical OncologyHepatologyMedicineFeasible AlternativeSurgery	2015	76
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma Juan L López-Cánovas, Mercedes del Río-Moreno, Helena García-Fernández, Cancer Letters MedicinePathologyLiver CancerCancer GeneticsSplicing Variant	2020	75
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management—Guidelines From the ILTS-SETH Consensus Conference Jordi Colmenero, Parissa Tabrizian, Prashant Bhangui, Transplantation Different DnmsSolid Organ TransplantationImmunologyPathologyAutoimmune Liver Disease	2021	73

Page 1